Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Location: Boston MA, Providence RI, Valhalla NY, The Bronx NY,
Sponsor: GT Medical Technologies, Inc.
Sex: All
Age: 0+
Code: NCT04427384
Recruiting
Active & Responsive
Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial
for
Acute Ischemic Stroke
Location: Boston MA, Providence RI, Worcester MA, Bay Shore NY,
Sponsor: Mercy Health Ohio
Sex: All
Age: 18 - 70+
Code: NCT05611242
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Evaluation of Safety and Effectiveness of Primary Hybrid Construct of Mobi-C and ACDF in the Treatment of Two-level Symptomatic Degenerative Disc Disease in the Cervical Spine.
for
Degenerative Disc Disease
Location: Southfield MI, Sacramento CA
Sponsor: Highridge Medical
Sex: All
Age: 22 - 69
Code: NCT06485206
Recruiting
Active & Responsive
Treatment of Moderate to Severe Refractory Crohn's Disease
for
Crohns Disease
Location: New York NY, Gainesville FL, Cleveland OH, Ann Arbor MI,
Sponsor: Tr1X, Inc.
Sex: All
Age: 18 - 65
Code: NCT06721962
Phase 1, Phase 2, Recruiting
Active & Responsive
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
for
Chronic Migraine
Location: Ann Arbor MI
Sponsor: University of Michigan
Sex: All
Age: 18 - 65
Code: NCT05769348
Recruiting
Active & Responsive
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe Hypertension
for
Hypertension, Acute Severe Hypertension, Hypertensive Emergency,
Location: Homestead FL, Port Orange FL, Fort Mill SC,
Sponsor: Kardigan, Inc.
Sex: All
Age: 18+
Code: NCT07511361
Phase 2, Recruiting
Active & Responsive
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
for
Autosomal Dominant Polycystic Kidney Disease
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Calico Life Sciences LLC
Sex: All
Age: 18 - 55
Code: NCT06902558
Phase 2, Recruiting
Active & Responsive
A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo
for
Non-segmental Vitiligo
Location: The Bronx NY, Quebec, Norfolk VA, Rockville MD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07431177
Phase 2, Recruiting
Active & Responsive
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
for
Liver Transplant
Location: Philadelphia PA, Baltimore MD, Durham NC, Miami FL,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 18+
Code: NCT06075745
Phase 2, Recruiting
Active & Responsive
ASSESS ALL ALS Study
for
Amyotrophic Lateral Sclerosis
Location: Boston MA, New Britain CT, Lebanon NH, New York NY,
Sponsor: St. Joseph's Hospital and Medical Center, Phoenix
Sex: All
Age: 18+
Code: NCT06578195
Recruiting
Active & Responsive
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
for
Peanut Allergies
Location: Boston MA, Tampa FL, Ann Arbor MI, Little Rock AR,
Sponsor: Mabylon AG
Sex: All
Age: 12 - 55
Code: NCT07287033
Phase 1, Recruiting
Active & Responsive
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Boston MA, New Haven CT, New York NY, New Brunswick NJ,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase 1, Recruiting
Active & Responsive
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension